Butylphthalide

CAS No. 6066-49-5

Butylphthalide( 3-Butylphthalide | 3-n-Butylphthalide | 3-n-Butylphathlide )

Catalog No. M19929 CAS No. 6066-49-5

Butylphthalide is an anti-cerebral-ischemia drug; first isolated from the seeds of Apium graveolens Linn.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 76 In Stock
100MG 27 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Butylphthalide
  • Note
    Research use only, not for human use.
  • Brief Description
    Butylphthalide is an anti-cerebral-ischemia drug; first isolated from the seeds of Apium graveolens Linn.
  • Description
    Butylphthalide is an anti-cerebral-ischemia drug; first isolated from the seeds of Apium graveolens Linn.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Old male SAMP8 mice and SAMR1 mice Dosage:40 mg/kg, 80 mg/kg, 160 mg/kg Administration:Orally daily, 60 days Result: Shorted escape latency time on day 7. Improved SAMP8 mice learning deficits.
  • Synonyms
    3-Butylphthalide | 3-n-Butylphthalide | 3-n-Butylphathlide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Neurological Disease
  • Indication
    Stroke

Chemical Information

  • CAS Number
    6066-49-5
  • Formula Weight
    190.24
  • Molecular Formula
    C12H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 55 mg/mL
  • SMILES
    CCCCC1OC(=O)c2ccccc12
  • Chemical Name
    3-Butyl-2-benzofuran-1(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhao W et al. 3-N-butylphthalide improves neuronal morphology after chronic cerebral ischemia. Neural Regen Res. 2014 Apr 1;9(7):719-26.
molnova catalog
related products
  • Uridine 5-(trihydrog...

    Uridine 5'-(trihydrogendiphosphate), P'-a-D-glucopyranosylester

  • D-Fructose-16-diphos...

    Fosfructose trisodium is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.

  • (D-Arg2,Lys4)-Dermor...

    DALDA is a potent and highly selective μ-opioid receptor agonist with a Ki of 1.69 nM. DALDA shows antinociceptive and respiratory effects.